Market Insights Health Medical Technology Medical Devices

Endoscopic Devices - Worldwide

Worldwide

Revenue in the Endoscopic Devices market market in the world is projected to reach €27.76bn in 2024.
Revenue is expected to exhibit an annual growth rate (CAGR 2024-2029) of 7.00%, resulting in a market volume of €38.94bn by 2029.
In a global context, the largest share of revenue will be generated the United States, with an expected revenue of €9,537.00m in 2024.
The global market for endoscopic devices is witnessing significant growth, driven by advancements in minimally invasive procedures and increasing demand for surgical precision.

Key regions: Italy, United Kingdom, Netherlands, Germany, Japan

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Endoscopic Devices Market within the Medical Devices sector is witnessing moderate growth globally, influenced by factors such as technological advancements, increasing prevalence of chronic diseases, and a growing demand for minimally invasive procedures.

Customer preferences: Consumers are increasingly favoring minimally invasive surgical options, driving demand for endoscopic devices that promise quicker recovery times and reduced hospital stays. This shift is particularly evident among younger demographics who prioritize efficient healthcare solutions that align with their active lifestyles. Additionally, heightened awareness of chronic diseases and preventive care is prompting patients to seek early intervention through advanced endoscopic procedures, reflecting a broader cultural shift towards proactive health management.

Trends in the market: The global Endoscopic Devices Market is experiencing a surge in demand driven by advancements in technology and an increasing preference for minimally invasive procedures. In North America, hospitals are integrating robotic-assisted endoscopy, enhancing precision and reducing recovery times. Meanwhile, in Asia-Pacific, the rise of healthcare infrastructure is facilitating broader access to endoscopic services, particularly in urban areas. In Europe, regulatory support for innovative endoscopic techniques is fostering rapid adoption, leading to improved patient outcomes. These trends underscore a significant shift towards comprehensive, patient-centric care, presenting opportunities for manufacturers to innovate and expand their product lines.

Local special circumstances: In Japan, the Endoscopic Devices Market is influenced by a rapidly aging population, driving demand for advanced minimally invasive procedures that reduce recovery times. The country's emphasis on high-quality healthcare standards fosters innovation in endoscopic technologies, supported by strong governmental regulations ensuring safety and efficacy. In contrast, in South Africa, a diverse healthcare landscape presents challenges, with disparities in access to cutting-edge endoscopic services. This leads to a growing focus on affordable solutions, tailored to local needs, driving market dynamics in unique ways.

Underlying macroeconomic factors: The Endoscopic Devices Market is significantly shaped by macroeconomic factors such as technological advancements, healthcare expenditure, and demographic shifts. In nations with robust economic growth and substantial healthcare investments, such as Japan, there is a strong push for innovative endoscopic solutions that enhance patient outcomes and procedural efficiency. Conversely, in countries like South Africa, economic disparities and varying fiscal policies can hinder access to advanced technologies, prompting a demand for cost-effective endoscopic devices tailored to local healthcare needs. Furthermore, global trends towards minimally invasive procedures and an aging population are universally driving the market's expansion, influencing both supply and demand dynamics across diverse regions.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.